Kevin Tang, 10% owner at Fulcrum Therapeutics, bought FULC on Jul 14, 2026
Data as of Oct 16
- Traded
- Jul 14, 2026
- Disclosed
- Jul 15, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
FULC since disclosure
+2.5%
Similar stocks (XLV) since disclosure
+11.6%
XLV — its sector index fund
Change in closing price from Jul 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYKevin Tang 10% ownerFULC Fulcrum Therapeutics, Inc.$382Kdisclosed Jul 15 · filed the same day
- ▲ BUYTang Capital Management LLC 10% ownerFULC Fulcrum Therapeutics, Inc.$382Kdisclosed Jul 15 · filed the same day
- ▲ BUYTang Capital Management LLC 10% ownerFULC Fulcrum Therapeutics, Inc.$272Kdisclosed Jul 15 · filed 1 day after the trade
- ▲ BUYTang Capital Management LLC 10% ownerFULC Fulcrum Therapeutics, Inc.$191Kdisclosed Jul 15 · filed 1 day after the trade
- ▲ BUYKevin Tang 10% ownerFULC Fulcrum Therapeutics, Inc.$191Kdisclosed Jul 15 · filed 1 day after the trade
- ▲ BUYTang Capital Management LLC 10% ownerFULC Fulcrum Therapeutics, Inc.$45.9Kdisclosed Jul 15 · filed 2 days after the trade
- ▲ BUYKevin Tang 10% ownerFULC Fulcrum Therapeutics, Inc.$45.9Kdisclosed Jul 15 · filed 2 days after the trade